Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Secondary prevention aims to reduce recurrent cardiovascular events and improve long-term survival. It should be initiated prior to discharge.
Drug / Strategy | Indication | Notes |
---|---|---|
🩸 DAPT | All ACS patients unless contraindicated | Aspirin + P2Y12 inhibitor ≥12 months |
💊 Anticoagulation | AF, LV thrombus, prosthetic valves | Triple ≤1 week → OAC + SAPT |
🧬 Statins | All post-ACS | Atorvastatin 80 mg nocte; LDL-C <1.4 mmol/L |
❤️ Beta-blockers | LVEF ≤40% | Reduce mortality & arrhythmia |
💊 ACEI/ARB | LVEF <40%, DM, HTN, CKD | Titrate to max tolerated dose |
💊 Eplerenone | Post-STEMI, LVEF ≤40% + DM/HF | Monitor K⁺ and renal function |
🚭 Lifestyle | All patients | Stop smoking, Mediterranean diet, cardiac rehab |
💡 Exam tip: Post-ACS secondary prevention is about “Drugs + Lifestyle + Rehab”. Always mention cardiac rehabilitation and HCC surveillance in cirrhotics.